48 results on '"Kurtulus, Sema"'
Search Results
2. Retraction: TIGIT predominantly regulates the immune response via regulatory T cells
3. T-cell receptor signal strength and epigenetic control of Bim predict memory CD8+ T-cell fate
4. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
5. Measuring brand image using a cognitive approach: Representing brands as a network in the Turkish airline industry
6. Induction and transcriptional regulation of the co-inhibitory gene module in T cells
7. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
8. Differentiation of Retailer Brand Buyers from Manufacturer Brand Buyers
9. Data from Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
10. Supplementary Data from Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
11. Bcl-2 Family Members and Lymphocyte Homeostasis
12. The role of consumer characteristics on cultural consumption tendency
13. CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses
14. TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
15. TIGIT predominantly regulates the immune response via regulatory T cells
16. CD8 Lineage-specific Regulation of Interleukin-7 Receptor Expression by the Transcriptional Repressor Gfi1
17. Abstract 581: bbT369, a dual-targeted and CBLB gene-edited autologous CART product, demonstrates anti-lymphoma activity in preclinical mouse models
18. Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
19. Differentiation of Retailer Brand Buyers from Manufacturer Brand Buyers
20. Assessment of CD4+ and CD8+ T Cell Responses Using MHC Class I and II Tetramers
21. Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
22. Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS): Updated Results from a Phase 1b Study
23. 10 A multiparameter flow cytometry assay to monitor natural killer cell proliferation and activation in immuno-oncology clinical trials
24. Contracting the ‘mus cells’– does down-sizing suit us for diving into the memory pool?
25. T-cell receptor signal strength and epigenetic control of Bim predict memory CD8+ T-cell fate
26. Abstract CT082: Phase (Ph) I/Ib study of NIZ985 with and without spartalizumab (PDR001) in patients (pts) with metastatic/unresectable solid tumors
27. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
28. Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
29. A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells
30. Abstract A10: A distinct gene module for T cell dysfunction uncoupled from T cell activation and controlled by metallothioneins
31. T-cell receptor signal strength and epigenetic control of Bim predict memory CD8+T-cell fate
32. Role of Conservatism in Turkish Users' Instagram Behavior.
33. Combination immunotherapy: Where do we go from here?
34. Mechanisms of TIGIT-driven immune suppression in cancer
35. Protecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development
36. Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus
37. Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of Bim
38. Additional loss of Bim rescues viral-specific effector and memory T cells, but not endogenous memory T cells or NK cells in IL-15-deficient mice (150.10)
39. STAT5 Is Critical To Maintain Effector CD8+ T Cell Responses
40. Bcl-2 maintains KLRG1low CD127high effector CD8+ and central memory CD8+ T cells by distinct mechanisms (132.9)
41. STAT5 is Critical to Maintain Effector CD8+, but not CD4+, T cell Responses (50.17)
42. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells
43. Protecting and rescuing the effectors: roles of differentiation and survival in the control of memory T cell development.
44. Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of Bim.
45. Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells.
46. Mechanisms Regulating Survival of Effector and Memory CD8+ T Cells
47. TIGIT predominantly regulates the immune response via regulatory T cells.
48. Assessment of CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.